drugset / Trial / NCT03103074

Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa

NCT03103074

RandomizedCrossoverTriple-blindTreatment

Summary

Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa

Timeline

Start
2017-06-01
Primary completion
2018-03-23
Completion
2018-09-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum Toxin Type B Unknown 50 iu Other